Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) had its price target increased by Piper Sandler from $16.00 to $19.00 in a report released on Tuesday, The Fly reports. Separately, StockNews.com upgraded shares of Ironwood Pharmaceuticals from a buy rating to a strong-buy rating in a research report on Wednesday, May 17th. Ironwood Pharmaceuticals Trading Up 0.7 […]